SLC6A3 and Cognitive impairment: APOE4 carriers in PPMI cohort had greater cognitive impairment when compared to non-carriersEffect of APOE4 toward enhanced cognitive function not associated with change in DAT uptake in the caudate nucleus and putamen from baseline (Year 2) to follow-up (Year 4)